> Hot share tips
> All the big AIM fraud exposés
> 300 articles and podcasts a month
> Original investigations by our experienced team
> No ads, no click-bait, no auto-play videos
Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
And so after more than a year of huff and puff and fascist corporate bullying by US giant Illumina, the High Court action with Premaitha (NIPT) starts tomorrow. Premaitha says:
The patents in issue in these proceedings fall into three families: European Patent (UK) 0 994 963; European Patent (UK) 1 981 995 and its divisional, European Patent (UK) 2 385 143; and European Patent (UK) 2 183 693 and its divisional, European Patent (UK) 2 514 842.
The trial will last three weeks and the verdict will be in the Autumn. Premaitha says that it has a strong defence and it also has the same EU comissioner who recently handed Google a £2 billion fine breathing down Illumina's neck accusing it of anti-competitive practices in Europe. Premaitha is confident.
Its patents outside Europe are not under challenge so it has deliberately targetted non European markets to limit downside. We think Premaitha will either win or that there will be a settlement. Either result will see the shares zoom. At 9.75p the stance is still BUY.
This article first appeared on HotStockRockets - to catch the next red hot share tip from the HotStockRockets team out shortly as well as two SCORCHERS we tipped on FRIDAY 30th June, for just £5 click HERE
Never miss a story.
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Comments are turned off for this article.
Search ShareProphets |
Stock market news |
Recent Comments |